Zura Bio Limited
NASDAQ: ZURA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Sandeep C. Kulkarni
- Employees
- 30
- Headquarters
- San Diego, United States
- IPO year
- 2023
- Market cap
- $277.0M
- Website
- https://zurabio.com
Loading ZURA…
Loading profile data…Frequently asked questions about ZURA
What does Zura Bio Limited (ZURA) do?
Zura Bio Limited is a clinical-stage biotechnology company headquartered in San Diego, California, dedicated to pioneering new therapeutic solutions for immune system and inflammatory diseases. Its key product candidates include ZB-168, an anti-IL7Rα inhibitor engineered to address conditions influenced by the IL7 and TSLP biological pathways. T...
Where does ZURA trade?
Zura Bio Limited (ZURA) trades on the NASDAQ Capital Market.
What sector is ZURA in?
Zura Bio Limited (ZURA) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Zura Bio Limited?
Sandeep C. Kulkarni is the chief executive officer of Zura Bio Limited (ZURA).
Where is Zura Bio Limited headquartered?
Zura Bio Limited is headquartered in United States.
Does ZURA pay a dividend?
Zura Bio Limited (ZURA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ZURA go public?
Zura Bio Limited (ZURA) completed its initial public offering in 2023.